| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/04/1997 | EP0776200A1 Composition and method for protection against drug dependency |
| 06/04/1997 | EP0776182A1 Therapeutic use of acetazolamide for the treatment of brain edema |
| 06/04/1997 | EP0776161A1 A method of selectively destroying neoplastic cells |
| 06/04/1997 | EP0697859B1 Stable, ingestable and absorbable nadh and nadph therapeutic compositions |
| 06/04/1997 | EP0559690B1 8-ENE-19, 11 beta-BRIDGED STEROIDS, THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM |
| 06/04/1997 | EP0553278B1 2-phenyl-and 2-thienyl-(2)-piperidine derivatives having neuroprotective properties |
| 06/04/1997 | EP0541617B1 1,4-disubstituted piperazines |
| 06/04/1997 | CN1151119A Medical use of bromelain |
| 06/04/1997 | CN1151116A Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
| 06/04/1997 | CN1035056C Method for preparing cyclic neurokinin A antagonists |
| 06/03/1997 | US5635537 8-substituted-2-aminotetralins |
| 06/03/1997 | US5635528 Intermediates to tetrahydro-beta-carbolines |
| 06/03/1997 | US5635526 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them |
| 06/03/1997 | US5635524 Cyclization; salt formation; separation; stimulant for beta-adrenergic receptors |
| 06/03/1997 | US5635518 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 06/03/1997 | US5635507 Pharmacologically active CNS compounds |
| 06/03/1997 | US5635503 Dihydropyridine npy antagonists: piperazine derivatives |
| 06/03/1997 | US5635502 Mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ACE |
| 06/03/1997 | US5635213 Pharmaceutical formulation |
| 06/03/1997 | US5635187 Adding phytogenic compounds to storage solution to increase organ preservation for transplantation |
| 06/03/1997 | US5635186 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 06/03/1997 | CA2004350C Propenone oxime ethers, a method of preparing them, and pharmaceutical compositions containing them |
| 05/29/1997 | WO1997019174A1 Virus protein antigens of the jc virus |
| 05/29/1997 | WO1997019084A1 Spiro-piperidine derivatives and their use as tachykinin antagonists |
| 05/29/1997 | WO1997019080A1 Novel intermediates and their use to prepare n,n'-bridged bisindolylmaleimides |
| 05/29/1997 | WO1997019066A1 New quinoxalindione derivatives, their preparation and use in medicaments |
| 05/29/1997 | WO1997019063A1 Pyrazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives |
| 05/29/1997 | WO1997019059A1 Novel substituted aryl compounds useful as modulators of acetylcholine receptors |
| 05/29/1997 | WO1997019053A1 Metalloproteinase inhibitors |
| 05/29/1997 | WO1997018838A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/29/1997 | WO1997018828A1 Inhibitors of cyclophilin rotamase activity |
| 05/29/1997 | WO1997018799A1 Use of a tnf alpha antagonist for treating neurogenic skin redness |
| 05/29/1997 | CA2238023A1 New quinoxalindione derivatives, their preparation and use in medicaments |
| 05/29/1997 | CA2237808A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/28/1997 | EP0775745A2 Cathepsin G-inhibiting aptamers |
| 05/28/1997 | EP0775704A1 Crystalline hydrochloride of (R)-(-)-2-[N-[4-(1,1-Dioxido-3-oxo-2,3-dihydrobenzisothiazol-2-yl)-butyl]-aminomethyl]-chroman |
| 05/28/1997 | EP0775213A1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 05/28/1997 | EP0775206A1 Dual hybrid system |
| 05/28/1997 | EP0775200A1 Recombinant kat enzyme and process for its preparation |
| 05/28/1997 | EP0775158A1 Organic compounds |
| 05/28/1997 | EP0775154A1 Pregnanes and cholanes as neurochemical initiators of change in hypothalamic function |
| 05/28/1997 | EP0775143A1 New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments |
| 05/28/1997 | EP0775140A1 Spiro-substituted azacyclic derivatives and their use as therapeutic agents |
| 05/28/1997 | EP0775138A1 TETRAHYDROPYRIDINYLMETHYL DERIVATIVES OF PYRROLO 2,3-b]PYRIDINE |
| 05/28/1997 | EP0775135A1 N-substituted 3-azabicyclo (3.2.0)heptane derivatives useful as neuroleptics |
| 05/28/1997 | EP0775132A1 (azetidin-1-ylalkyl)lactams as tachykinin antagonists |
| 05/28/1997 | EP0775118A1 Benzimidazole derivatives having dopaminergic activity |
| 05/28/1997 | EP0775113A1 N-substituted azabicycloheptane derivatives useful as neuroleptics |
| 05/28/1997 | EP0774962A1 Use of dha as a pharmaceutical composition |
| 05/28/1997 | EP0774961A1 Use of selegilin in the treatment of epilectic conditions |
| 05/28/1997 | EP0717620A4 Substituted 2-aminotetralins |
| 05/28/1997 | EP0668851B1 A novel arylpropionic derivative, a process for the preparation and the use thereof as an analgesic agent |
| 05/28/1997 | EP0660822B1 Cyclic benzylamino, benzylamido and benzylimido derivatives as antipsychotic agents |
| 05/28/1997 | EP0641330A4 Gaba and l-glutamic acid analogs for antiseizure treatment. |
| 05/28/1997 | EP0526511B1 Method and composition for treatment of central nervous systems disease states associated with abnormal amyloid beta protein |
| 05/28/1997 | DE19545251A1 Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln New quinoxalinedione derivatives, their preparation and use in medicaments |
| 05/28/1997 | DE19543553A1 VP-Antigene des JC-Virus VP-antigens of the JC virus |
| 05/28/1997 | CN1150804A Fibroblast growth factor-10 |
| 05/28/1997 | CN1150803A Pyrazolo and pyrrolopyridines |
| 05/28/1997 | CN1150802A Benzoylecgonine, ecgonine and ecgonidine derivatives |
| 05/28/1997 | CN1150799A Benzoheterocyclic derivatives |
| 05/28/1997 | CN1150545A Tengxiling fumigant |
| 05/28/1997 | CN1035006C Method for preparing peptide of effect having bradykinin-antagonistic agent |
| 05/28/1997 | CA2163828A1 Process for screening factors on a paralysis model and process for preparing said model |
| 05/27/1997 | US5633382 Histamine H3 -receptor antagonists and therapeutic uses thereof |
| 05/27/1997 | US5633379 3-heteroaliphatyl- and 3-hetero(aryl)aliphatyl-2(1H)-quinolone derivatives |
| 05/27/1997 | US5633283 Method for treating multiple sclerosis |
| 05/27/1997 | US5633276 Melatonin system disorders |
| 05/27/1997 | US5633270 Thiazolidine derivatives, preparation thereof and drugs containing samem |
| 05/27/1997 | US5633266 Azacyclic compounds compositions containing them and their use as tachykinin antagonists |
| 05/27/1997 | US5633238 Method for the treatment of schizophrenia |
| 05/27/1997 | US5633232 Tachykinin antagonist dipeptides |
| 05/27/1997 | US5633228 Prevention and treatment of peripheral neuropathy |
| 05/27/1997 | US5633000 Subcutaneous implant |
| 05/27/1997 | US5632981 Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
| 05/23/1997 | CA2190700A1 Crystalline hydrochloride of (r)-(-)-2 n-[4-(1,1-dioxido-3-oxo-2, 3-dihydrobenzisothiazol-2-yl)-butyl]-aminomethyl-chroman |
| 05/22/1997 | WO1997018230A1 Cloning and expression of beta app-c100 receptor (c100-r) |
| 05/22/1997 | WO1997018223A1 Improved method and agents for inhibiting protein aging |
| 05/22/1997 | WO1997018212A1 Aryl and heteroaryl purine compounds |
| 05/22/1997 | WO1997018208A1 Quinoline derivatives as type iv phosphodiesterase inhibitors |
| 05/22/1997 | WO1997018206A1 Morpholine derivatives and their use as therapeutic agents |
| 05/22/1997 | WO1997018204A1 Substituted tetrahydropyridine derivatives acting on 5-ht receptors |
| 05/22/1997 | WO1997018191A1 Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents |
| 05/22/1997 | WO1997017978A1 Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs |
| 05/22/1997 | WO1997017971A1 Use of epinastine in the treatment of pain |
| 05/22/1997 | WO1997017962A1 Method for treating anxiety |
| 05/22/1997 | WO1997017956A1 Method for treating anxiety |
| 05/22/1997 | WO1997017955A1 Method for treating anxiety |
| 05/22/1997 | WO1997017954A1 Analgesic compounds and uses thereof |
| 05/22/1997 | WO1997017952A1 Excitatory amino acid receptor antagonists |
| 05/22/1997 | WO1997017950A1 Shoulder prosthesis |
| 05/22/1997 | WO1997017948A1 Formulation for respiratory tract administration |
| 05/22/1997 | WO1997005252A3 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
| 05/22/1997 | WO1997005241A3 Methods and compositions for identifying morphogen analogs |
| 05/22/1997 | CA2238007A1 Cloning and expression of .beta.app-c100 receptor (c100-r) |
| 05/22/1997 | CA2237598A1 Excitatory amino acid receptor antagonists |
| 05/22/1997 | CA2237565A1 Improved method and agents for inhibiting protein aging |
| 05/22/1997 | CA2237558A1 Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents |
| 05/22/1997 | CA2237404A1 Excitatory amino acid receptor antagonists |
| 05/22/1997 | CA2237384A1 Analgesic compounds and uses thereof |